Skip to main content
. 2022 Aug 4;12:966624. doi: 10.3389/fonc.2022.966624

Table 4.

Relationship between CTC levels before neoadjuvant therapy and pCR in 50 patients.

CTC status Pathology results, n (%)
pCR non-pCR
TUMORFISHER system
 Positive 20 (74.1%) 7 (25.9%)
 Negative 9 (39.1%) 14 (60.9%)
 χ2 value 6.226
p value 0.013
CellSearch system
 Positive 11 (73.3%) 4 (26.7%)
 Negative 18 (51.4%) 14 (48.6%)
 χ2 value 2.068
p value 0.15